Mark Campbell

Regulatory Consultant

Mark Campbell is a microbiologist and dedicated biosafety professional. He holds a BS in Biology, MS in Microbiology, and a PhD in Environmental and Occupational Health. Mark previously worked as a bench scientist doing classical microbiology and molecular biology research in support of viral and bacterial-based vaccine platforms. A valuable research career helped him transition into the biosafety field serving as the Biosafety Officer for Saint Louis University for over two decades prior to practicing Biosafety as a full-time consultant. In his spare time, Mark enjoys homebrewing, home improvement projects, freestyle jump rope, and making cars go fast.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.